AI Verdict
RVYL has stronger fundamentals based on our AI analysis.
RVYL vs RVPH Fundamental Comparison
| Metric | RVYL | RVPH |
|---|---|---|
| Revenue | $8.3M | $122,867.0 |
| Net Income | $-13.1M | $-19.9M |
| Net Margin | -157.3% | -16,167.8% |
| ROE | N/A | -229.7% |
| ROA | -56.0% | -124.8% |
| Current Ratio | 0.82x | 2.08x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.78 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RVYL vs RVPH: Frequently Asked Questions
Is RVYL or RVPH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RVYL has stronger fundamentals. RVYL is rated STRONG SELL (95% confidence) while RVPH is rated STRONG SELL (90% confidence). This is not investment advice.
How does RVYL compare to RVPH fundamentally?
RYVYL Inc. has ROE of N/A vs REVIVA PHARMACEUTICALS HOLDINGS, INC.'s -229.7%. Net margins are -157.3% vs -16,167.8% respectively.
Which stock pays higher dividends, RVYL or RVPH?
RVYL has a dividend yield of N/A or no dividend while RVPH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RVYL or RVPH for long term?
For long-term investing, consider that RVYL has STRONG SELL rating with 95% confidence, while RVPH has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RVYL vs RVPH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVYL vs RVPH, the AI consensus favors RVYL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.